The UChicago-backed digital home insurance provider is joining forces with Omnichannel Acquisition Corp at a valuation of just over $1bn.

Harvard spinout TScan Therapeutics has successfully listed on the Nasdaq Global Market.

The IGBMC spinout was set up by Satt Conectus and is now seeking a listing in the US with a price range of $15 to $17.

MIT’s battery technology spinout will collect $200m in a private investment in public equity financing and list on the New York Stock Exchange.

Th heart disease treatment developer has secured $248m in funding since being formed to exploit UT Southwestern and Gladstone Institute research.

University of Washington spinout Icosavax has filed for an initial public offering on the Nasdaq Global Select Market, with financial terms yet to be set.

UC Berkeley’s cell therapy developer has filed for an initial public offering.

Less than a year after raising $72.6m in its series A round, Aerovate Therapeutics has gone public following an IPO worth more than $121m.

The open online education platform’s founding institutions MIT and Harvard plan to sell edX to edtech developer 2U in a deal worth $800m.

Schunk has agreed to acquire a majority stake in Fraunhofer spinout Pulsar Photonics, which produces ultrashort-pulse laser technology.